Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

MD Anderson and Virogin Biotech partner to accelerate the development of investigational treatments for advanced cancers

The University of Texas MD Anderson Cancer Center and Virogin Biotech today announced a strategic collaboration to accelerate the development of investigational treatments, including oncolytic viruses and immunotherapies, for patients with advanced cancers.

7 Sep 2022

First nasal vaccine for COVID-19 approved in India for emergency use

The world's first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International Limited in India.

7 Sep 2022

Novel skin imaging technology improves the accuracy of basal cell carcinoma diagnosis

A novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC) – the most frequent skin cancer – compared to clinical and dermoscopic examinations alone, according to new research being presented at the 31st European Academy of Dermatology and Venereology Congress.

7 Sep 2022

Incidence of early onset cancers has increased globally, study reveals

Over recent decades, more and more adults under the age of 50 are developing cancer. A study conducted by researchers from Brigham and Women's Hospital reveals that the incidence of early onset cancers (those diagnosed before age 50), including cancers of the breast, colon, esophagus, kidney, liver, and pancreas among others, has dramatically increased around the world, with this drastic rise beginning around 1990.

6 Sep 2022

Cedars-Sinai investigators identify 15 cancer disparities in L.A. County

People in Los Angeles County experience differences in cancer risk and survival depending on a variety of factors such as race/ethnicity, gender, sexual orientation, geographic location and socioeconomic status, according to a new study by investigators at Cedars-Sinai Cancer.

6 Sep 2022

Study provides a comprehensive view of the genomics of all childhood ALL subtypes

Scientists have created a roadmap of the genetic mutations present in the most common childhood cancer, acute lymphoblastic leukemia (ALL).

1 Sep 2022

Integrating recent advances in multi-omics tumor profiling into precision cancer treatment

Tumors have significant differences depending on the person affected, even if they are the same cancer, such as breast cancer.

1 Sep 2022

Study opens a window of opportunity to design RAF1 degraders against lung adenocarcinomas

One of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes -genes that cause cancer when mutated - are responsible for a quarter of all human cancers, including the three tumor types with the highest mortality rates: lung adenocarcinoma, colorectal carcinoma and pancreatic ductal adenocarcinoma.

1 Sep 2022

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers.

1 Sep 2022

Moffitt study uses computer modeling to demonstrate the impact of skin homeostasis on driver and passenger mutations

All normal human tissues acquire mutations over time. Some of these mutations may be driver mutations that promote the development of cancer through increased proliferation and survival, while other mutations may be neutral passenger mutations that have no impact on cancer development.

30 Aug 2022

Using deep learning to guide the selection of chemotherapy after surgery for colorectal cancer patients

Among patients with colorectal cancer spread to lymph nodes, a deep learning marker can identify one-third with excellent prognosis and consequently no need for adjuvant chemotherapy.

30 Aug 2022

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

A study conducted by researchers in Brazil, Australia, Austria and the United States has made significant discoveries about a type of pediatric cancer with no approved drugs for treatment and with a low survival rate.

29 Aug 2022

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumor-induced immunosuppression.

29 Aug 2022

New advice aims to reduce the cardiac side effects of cancer treatment

The first European Society of Cardiology Guideline on cardio-oncology is published online today in European Heart Journal.

26 Aug 2022

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

25 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting.

24 Aug 2022

Optimized human small intestinal organoids can help better study the functioning of small intestines

Researchers from the Organoid group (formerly the Clevers group) have improved human small intestinal organoids – miniature versions of the small intestine.

24 Aug 2022

Study suggests no lasting setback for urologists in training after COVID-19 pandemic

After the onset of the COVID-19 pandemic, urology training programs saw a precipitous drop in opportunities for residents to gain hands-on surgical experience, reports a study in Urology Practice, an Official Journal of the American Urological Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.

24 Aug 2022

Researchers reveal details of two key transition points in the development of pancreatic tumors

Pancreatic cancer has few treatment options and limited survival, with only 9% of patients still living five years after diagnosis.

22 Aug 2022

Oncology News and Research

Further Reading

MD Anderson and Virogin Biotech partner to accelerate the development of investigational treatments for advanced cancers

First nasal vaccine for COVID-19 approved in India for emergency use

Novel skin imaging technology improves the accuracy of basal cell carcinoma diagnosis

Incidence of early onset cancers has increased globally, study reveals

Cedars-Sinai investigators identify 15 cancer disparities in L.A. County

Study provides a comprehensive view of the genomics of all childhood ALL subtypes

Integrating recent advances in multi-omics tumor profiling into precision cancer treatment

Study opens a window of opportunity to design RAF1 degraders against lung adenocarcinomas

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Moffitt study uses computer modeling to demonstrate the impact of skin homeostasis on driver and passenger mutations

Using deep learning to guide the selection of chemotherapy after surgery for colorectal cancer patients

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

New advice aims to reduce the cardiac side effects of cancer treatment

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

The risk of adverse reactions when herbal medications are taken with cancer drugs

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Optimized human small intestinal organoids can help better study the functioning of small intestines

Study suggests no lasting setback for urologists in training after COVID-19 pandemic

Researchers reveal details of two key transition points in the development of pancreatic tumors

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News